BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• 

  Drug pricing

  More Than Half of IRA Negotiation Savings to Come From Three Drugs: Report

  Amgen’s Enbrel, Bristol Myers Squibb’s Eliquis and Johnson & Johnson’s Stelara will account for 51.4% of the Inflation Reduction Act’s drug price negotiation savings in 2026, according to the Brookings Institution.

  August 20, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  News

  Video Recap - Regulatory Agility: The Intersection of AI and QARA

  August 20, 2024

   · 

  1 min read

   · 

  BioSpace Insights
• Press Releases

  NETRAMARK PROVIDES Q3 BUSINESS UPDATE AND HIGHLIGHTS PROGRESS

  August 20, 2024

   · 

  7 min read
• Press Releases

  Alife Health Study Shows Potential of AI Model Improving Ovarian Stimulation Decisions in IVF Treatment

  August 20, 2024

   · 

  2 min read
• Press Releases

  Elanco Announces Credelio Quattro Moves to Final FDA Administrative Review

  August 20, 2024

   · 

  7 min read
• Press Releases

  XORTX Announces Presentation at American Society of Nephrology – Kidney Week 2024

  August 20, 2024

   · 

  7 min read
• Press Releases

  RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE™ (lazertinib) approved in the U.S. as a first-line chemotherapy-free treatment for patients with EGFR-mutated advanced lung cancer

  August 20, 2024

   · 

  34 min read
• Press Releases

  Nanox Announces Second Quarter of 2024 Financial Results and Provides Business Update

  August 20, 2024

   · 

  24 min read
• Press Releases

  GRIN Therapeutics to Present New Data from Honeycomb Study at ILAE Europe Epilepsy Congress

  August 20, 2024

   · 

  3 min read
• FDA

  SI-BONE, Inc. Receives 510(k) Clearance and FDA Breakthrough Device Designation for Pelvic Fracture Fixation System

  August 20, 2024

   · 

  3 min read